1 active not recruiting, 1 recruiting. 1 Phase 1, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 1 | Recruiting 1 |
| Phase 2 | 1 | Active not recruiting 1 |
Follow Terrence J Bradley, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Venetoclax and Bomedemstat in Patients With Relapsed/Refractory Acute Myeloid Leukemia Bomedemstat, Venetoclax - Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia | Phase 1 | Recruiting | Terrence J Bradley, MD | 18 | 2022-11-19 | 2026-01-08 |
| IMG-7289 in Patients With Essential Thrombocythemia (ET) or Polycythemia Vera (PV) IMG-7289 - Essential Thrombocythemia, Polycythemia Vera | Phase 2 | Active not recruiting | Terrence J Bradley, MD | 4 | 2020-10-02 | 2026-01-07 |
Leukemia, Myeloid, Acute (1) · Polycythemia Vera (1) · Thrombocythemia, Essential (1)
bomedemstat (2) · venetoclax (1)
United States (2)